For research use only. Not for therapeutic Use.
Bepranemab(Cat No.:I042158)is an investigational monoclonal antibody designed to target tau, a protein that forms twisted tangles in the brains of individuals with neurodegenerative diseases like Alzheimer’s disease. Tau accumulation is associated with cognitive decline and neurodegeneration. By binding to tau, bepranemab aims to prevent the formation of tau tangles or promote their clearance, potentially slowing disease progression. It is being studied in clinical trials to assess its safety, efficacy, and ability to improve cognitive function in patients with Alzheimer’s disease and other tau-related neurodegenerative disorders.
Catalog Number | I042158 |
CAS Number | 2244960-75-4 |
Purity | ≥95% |